Publicaciones en colaboración con investigadores/as de Emory University School of Medicine (2)

2023

  1. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

    The Lancet, Vol. 401, Núm. 10378, pp. 733-746

2014

  1. Dacomitinib versus erlotinib in patients with advanced-stage, previously treated non-small-cell lung cancer (ARCHER 1009): A randomised, double-blind, phase 3 trial

    The Lancet Oncology, Vol. 15, Núm. 12, pp. 1369-1378